Browse Category

NASDAQ:RGC 23 December 2025 - 2 July 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Regencell Bioscience (NASDAQ:RGC) slumps 63% under May offer after rebound fades

Regencell Bioscience Holdings Limited dropped Thursday morning after jumping on Wednesday. The move came as biotech funds traded higher. The stock is trading out of sync with the sector and is still well under the price from the company’s share sale six weeks back.

2 July 2026

Biotechnology·Nasdaq·NASDAQ:RGC·Stock Market

Regencell Bioscience stock rebound leaves May share buyers deep underwater

Regencell Bioscience Holdings Limited jumped on Wednesday, but the sharper investor signal sat below the one-day gain: the stock closed at $8.03, far under the $20.30 price paid in a registered-direct offering that closed six weeks ago. Google Finance showed the stock up 31.86% on the day, with a $6.00 low, an $8.78 high and 2.55 million shares traded.

2 July 2026

NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) stock jumps nearly 10% in choppy Nasdaq trade

Regencell Bioscience Holdings shares jumped roughly 9.8% to $27.43 by 12:35 p.m. EST Monday, following a volatile session that highlighted the stock’s usual sharp intraday moves. Trading volume hit around 241,000 shares.

2 February 2026

Biotechnology·NASDAQ:RGC·Stock Market

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience Holdings Ltd shares climbed 16.3% to $35.77 in premarket trading Friday, building on a steep rise from the day before.

23 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) stock price jumps 37% again as the latest swing hits Nasdaq screens

Shares of Regencell Bioscience Holdings Limited jumped roughly 37% to $29.98 in afternoon trading Thursday, rebounding sharply from earlier dips. The stock swung between $20.91 and $30.78, with around 1 million shares changing hands by 1:19 p.m. EST.

22 January 2026

Biotechnology·Nasdaq·NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

Shares of Regencell Bioscience Holdings Limited dropped over 20% on Tuesday, continuing a volatile streak that has kept the Nasdaq-listed microcap in the spotlight on momentum trackers.

13 January 2026

NASDAQ:RGC

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience Holdings Ltd shares closed Friday up 10.6% at $45.79, recovering sharply after dipping roughly 15% during the session. The Nasdaq-listed stock kicked off the day at $36.08 and swung between a low of $35.13 and a high of $50.92.

11 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded.

9 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience Holdings Limited shares were down 18.5% at $43.10 on Thursday, a sharp reversal after an early spike that pushed the Nasdaq-listed stock as high as $69.97. The shares opened at $62.00 and later fell to $36.01.

8 January 2026

Nasdaq·NASDAQ:RGC·Stock Market

Regencell Bioscience stock jumps 27% again as RGC’s wild swings draw momentum traders

Regencell Bioscience Holdings Limited shares jumped about 27% to $41.90 in morning trading on Wednesday, extending a sharp two-day run for the Nasdaq-listed microcap. The stock has swung between $34.11 and $43.74 so far in the session, with nearly 1.0 million shares traded.

7 January 2026

NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

Regencell Bioscience Holdings Ltd shares rose 18.3% to $31.99 on Tuesday, after touching $34.40 earlier and sliding as low as $26.60. The Nasdaq-listed stock was last up $4.95 from Monday’s close of $27.04, with about 850,000 shares traded.

6 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience Holdings Limited shares were down 4.8% at $21.79 as of 11:51 a.m. ET, after trading between $21.44 and $23.11 in a choppy session.

31 December 2025

NASDAQ:RGC·Stock Market

Regencell Bioscience stock jumps 11% as RGC volatility returns ahead of Tuesday’s open

Regencell Bioscience Holdings Ltd shares were last indicated at $23.48 in off-hours trade ahead of Tuesday’s U.S. session.

30 December 2025

NASDAQ:RGC

Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stock: Shares Slide Into the Weekend After a 14% Drop—What to Watch Before Monday’s Open

Regencell Bioscience Holdings Limited heads into the weekend with traders focused on one thing: volatility. RGC stock finished the last regular session sharply lower, while the broader market logged weekly gains in a quiet, holiday-shortened week—setting up a potentially jumpy start to the next session when U.S. equities reopen on Monday, Dec. 29. Investopedia

28 December 2025

Biotechnology·Nasdaq·NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) Stock: What to Know After a Sharp Friday Slide, Latest Headlines, and the Setup for Monday

Regencell Bioscience Holdings Limited is heading into the final trading stretch of 2025 under a brighter spotlight after a volatile week capped by a steep Friday drop—one that stood out even as the broader U.S. market barely moved in a quiet, post-Christmas session.

28 December 2025

NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) Stock Slides 14% Into the Weekend: Latest News, Risks, and What to Watch Monday

Regencell Bioscience Holdings Limited stock heads into the weekend after a sharp Friday pullback, closing at $21.16, down 13.98% from the prior close of $24.60, in a move that put the name on multiple “top losers” radars as U.S. markets wrapped up a quiet post-Christmas session. aaii.com+2Investing.com+2

27 December 2025

NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) Stock Drops in Thin Post‑Christmas Trading as DOJ Probe and “Going Concern” Warning Keep Risk Front and Center

While the broader U.S. market is mostly drifting near record territory in subdued post‑holiday volume, Regencell Bioscience Holdings Limited is doing what it’s become famous for in 2025: moving a lot, on not much liquidity. AP News

26 December 2025

NASDAQ:RGC·Stock Market

Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited is once again reminding markets that “biotech stock” plus “low float” can equal “physics optional.” By the close of trading on December 24, RGC finished at $24.60, down 2.57% from the prior close of $25.25, after trading between $24.60 and $26.42 on the day, with roughly 348K shares traded. StockAnalysis+1

24 December 2025

Financial Forecasts·NASDAQ:RGC

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited is having one of those “stock market is a strange animal” moments again: the share price is moving sharply on a story dominated less by traditional fundamentals and more by market structure—low float, extreme volatility, and ongoing legal overhang.

24 December 2025

Biotechnology·NASDAQ:RGC·Stock Market

Regencell Bioscience (RGC) Stock Today: Price Surge Extends December Rally as DOJ Probe and “Going Concern” Risks Loom

December 23, 2025 — Regencell Bioscience Holdings Limited is back in the spotlight on Tuesday after another sharp move higher, extending a volatile December run that’s pulled in momentum traders—and raised fresh questions about fundamentals, governance, and legal risk.

23 December 2025

NASDAQ:RGC

1 2 Next

NASDAQ:RGC 23 December 2025 - 2 July 2026

Regencell Bioscience (NASDAQ:RGC) slumps 63% under May offer after rebound fades

Regencell Bioscience stock rebound leaves May share buyers deep underwater

Regencell Bioscience (RGC) stock jumps nearly 10% in choppy Nasdaq trade

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience (RGC) stock price jumps 37% again as the latest swing hits Nasdaq screens

Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience stock jumps 27% again as RGC’s wild swings draw momentum traders

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience stock jumps 11% as RGC volatility returns ahead of Tuesday’s open

Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stock: Shares Slide Into the Weekend After a 14% Drop—What to Watch Before Monday’s Open

Regencell Bioscience (RGC) Stock: What to Know After a Sharp Friday Slide, Latest Headlines, and the Setup for Monday

Regencell Bioscience (RGC) Stock Slides 14% Into the Weekend: Latest News, Risks, and What to Watch Monday

Regencell Bioscience (RGC) Stock Drops in Thin Post‑Christmas Trading as DOJ Probe and “Going Concern” Warning Keep Risk Front and Center

Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience (RGC) Stock Today: Price Surge Extends December Rally as DOJ Probe and “Going Concern” Risks Loom

TechStock² Updates

Berkshire Hathaway’s $7.8 Billion Repurchase Strategy Puts Greg Abel to the Test on Monday

Airbnb (NASDAQ:ABNB) Rallies 17% With AI Savings Sending Stock Past Wall Street Target

DoubleVerify (NYSE:DV) faces 3% remaining upside as deal with Nielsen pushes expected close to 2027

Bob’s Discount Furniture (NYSE:BOBS) meets 11.4% margin challenge in H2

The Trade Desk (NASDAQ:TTD) Drops 21.9% as Q3 Outlook Points to 25% Adjusted EBITDA Margin

Top Stock Picks

AerCap

Constellation Energy

Cheniere Energy

Walt Disney

AIG

Live updates

Investment Disclaimer